Biocartis Group N.V.
BIOGF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $57 | $24 |
| % Growth | -5.1% | -99.9% | 138% | – |
| Cost of Goods Sold | $0 | $0 | $30 | $17 |
| Gross Profit | -$0 | -$0 | $28 | $7 |
| % Margin | -6.3% | -9.1% | 48.2% | 29.7% |
| R&D Expenses | $0 | $0 | $38 | $24 |
| G&A Expenses | $0 | $0 | $4 | $2 |
| SG&A Expenses | $0 | $0 | $9 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $5 | $2 |
| Other Operating Expenses | -$0 | $0 | $27 | $0 |
| Operating Expenses | $0 | $0 | $74 | $38 |
| Operating Income | -$0 | -$0 | -$47 | -$31 |
| % Margin | -70.1% | -68.1% | -81.9% | -129.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$19 | -$5 |
| Pre-Tax Income | -$0 | -$0 | -$66 | -$36 |
| Tax Expense | -$0 | -$0 | -$0 | -$0 |
| Net Income | -$0 | -$0 | -$65 | -$36 |
| % Margin | -105.5% | -117.3% | -113.7% | -148.1% |
| EPS | -0.34 | -0.58 | -0.5 | -0.62 |
| % Growth | 41.4% | -16% | 19.4% | – |
| EPS Diluted | -0.34 | -0.58 | -0.5 | -0.62 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 58 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 58 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $0 | $0 | $11 | $5 |
| Depreciation & Amortization | $0 | $0 | $10 | $5 |
| EBITDA | -$0 | -$0 | -$44 | -$26 |
| % Margin | -52.6% | -51.4% | -76.5% | -108.9% |